DL-Theanine
Based on 1 Customer Validation
DL-Theanine (DL-Glutamic acid γ-ethyl amide) is an antimetabolite of L-glutamic acid, and exhibits antibacterial activity against Staphylococcus aureus and Escherichia coli. DL-Theanine shows no significant inhibitory activity against bacterial glutamate decarboxylase. DL-Theanine can be used in studies related to bacterial infections.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 34271-54-0
- Formel: C7H14N2O3
- Molecular Weight:174.20
-
Speicherung:
Store at room temperature 3 years.
In solvent -80°C, 2 years , -20°C, 1 year
Biologische Aktivität
Beschreibung
In Vitro
DL-Theanine (0.02 M; 30 min) acts as a test substrate, and free aminoacylase has a Km value of 3.6 mM for DL-Theanine under its own optimal assay conditions of 42 °C and pH 7[2].
DL-Theanine (0.02 M) acts as a test substrate, and aminoacylase immobilized on crosslinked PVA nanofibrous membranes has reduced substrate affinity for DL-Theanine, but greatly improved thermostability, storage stability, and reusability[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS. Nr. 34271-54-0
-
Appearance Solid
-
Molecular Weight 174.20
-
Formel C7H14N2O3
-
Color White to off-white
-
SMILES
OC(C(N)CCC(NCC)=O)=O
-
Synonyms
DL-Glutamic acid γ-ethyl amide; Nγ-Ethyl-DL-glutamine
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Store at room temperature 3 years
In solvent -80°C 2 years -20°C 1 year
Protokoll
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Reinheit & Dokumentation
-
Data Sheet (265 KB)
-
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Keywords
- DL-Theanine
- 34271-54-0
- DL-Glutamic acid γ-ethyl amide
- Nγ-Ethyl-DL-glutamine
- Bacterial
- bacterial glutamic decarboxylase
- bacterial infection
- crosslinked PVA nanofibrous membranes
- aminoacylase
- L-glutamic acid antimetabolite
- bacterial growth
- Escherichia coli
- Staphylococcus aureus
- antibacterial activity
- free aminoacylase
- Inhibitor
- inhibitor
- inhibit